SVAS BIOSANA SPA (SVS.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:SVS - IT0005469264 - Common Stock
8.48 EUR
+0.18 (+2.17%)
Taking everything into account, SVS scores 5 out of 10 in our fundamental rating. SVS was compared to 65 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of SVS while its profitability can be described as average. SVS has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination!
1. Profitability
1.1 Basic Checks
In the past year SVS was profitable.
SVS had a negative operating cash flow in the past year.
In the past 5 years SVS has always been profitable.
SVS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
SVS has a Return On Assets (3.75%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 10.43%, SVS is in the better half of the industry, outperforming 64.62% of the companies in the same industry.
The Return On Invested Capital of SVS (8.04%) is better than 66.15% of its industry peers.
SVS had an Average Return On Invested Capital over the past 3 years of 6.63%. This is below the industry average of 9.72%.
The 3 year average ROIC (6.63%) for SVS is below the current ROIC(8.04%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.75% | ||
| ROE | 10.43% | ||
| ROIC | 8.04% |
ROA(3y)3.03%
ROA(5y)2.75%
ROE(3y)8.2%
ROE(5y)7.97%
ROIC(3y)6.63%
ROIC(5y)6.34%
1.3 Margins
SVS has a Profit Margin (5.09%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of SVS has grown nicely.
SVS has a Operating Margin (8.71%) which is in line with its industry peers.
SVS's Operating Margin has improved in the last couple of years.
SVS has a worse Gross Margin (26.17%) than 87.69% of its industry peers.
SVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.71% | ||
| PM (TTM) | 5.09% | ||
| GM | 26.17% |
OM growth 3Y3.27%
OM growth 5Y3.94%
PM growth 3Y7.81%
PM growth 5Y7.66%
GM growth 3Y-3.21%
GM growth 5Y-2.88%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SVS is still creating some value.
SVS has less shares outstanding than it did 1 year ago.
SVS has less shares outstanding than it did 5 years ago.
SVS has a better debt/assets ratio than last year.
2.2 Solvency
SVS has an Altman-Z score of 1.81. This is a bad value and indicates that SVS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.81, SVS is doing worse than 63.08% of the companies in the same industry.
SVS has a Debt/Equity ratio of 0.62. This is a neutral value indicating SVS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.62, SVS is doing worse than 66.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.81 |
ROIC/WACC1.14
WACC7.07%
2.3 Liquidity
SVS has a Current Ratio of 1.82. This is a normal value and indicates that SVS is financially healthy and should not expect problems in meeting its short term obligations.
SVS has a Current ratio of 1.82. This is comparable to the rest of the industry: SVS outperforms 56.92% of its industry peers.
A Quick Ratio of 1.34 indicates that SVS should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.34, SVS is doing good in the industry, outperforming 63.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.34 |
3. Growth
3.1 Past
SVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.41%, which is quite impressive.
Measured over the past years, SVS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.97% on average per year.
Looking at the last year, SVS shows a quite strong growth in Revenue. The Revenue has grown by 9.07% in the last year.
SVS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.34% yearly.
EPS 1Y (TTM)24.41%
EPS 3Y23.97%
EPS 5Y19.97%
EPS Q2Q%34.09%
Revenue 1Y (TTM)9.07%
Revenue growth 3Y14.06%
Revenue growth 5Y10.34%
Sales Q2Q%21.03%
3.2 Future
SVS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.83% yearly.
Based on estimates for the next years, SVS will show a quite strong growth in Revenue. The Revenue will grow by 9.07% on average per year.
EPS Next Y33.33%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
EPS Next 5YN/A
Revenue Next Year19.23%
Revenue Next 2Y11.86%
Revenue Next 3Y9.07%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 6.68, the valuation of SVS can be described as very cheap.
100.00% of the companies in the same industry are more expensive than SVS, based on the Price/Earnings ratio.
SVS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.46.
Based on the Price/Forward Earnings ratio of 5.75, the valuation of SVS can be described as very cheap.
Based on the Price/Forward Earnings ratio, SVS is valued cheaply inside the industry as 96.92% of the companies are valued more expensively.
SVS is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.10, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.68 | ||
| Fwd PE | 5.75 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SVS is valued cheaper than 92.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 4.65 |
4.3 Compensation for Growth
SVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SVS's earnings are expected to grow with 14.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.2
PEG (5Y)0.33
EPS Next 2Y17.92%
EPS Next 3Y14.83%
5. Dividend
5.1 Amount
SVS has a Yearly Dividend Yield of 2.98%.
SVS's Dividend Yield is rather good when compared to the industry average which is at 2.15. SVS pays more dividend than 93.85% of the companies in the same industry.
SVS's Dividend Yield is a higher than the S&P500 average which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.98% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
19.64% of the earnings are spent on dividend by SVS. This is a low number and sustainable payout ratio.
DP19.64%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
BIT:SVS (11/21/2025, 7:00:00 PM)
8.48
+0.18 (+2.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners6.55%
Inst Owner ChangeN/A
Ins Owners64.79%
Ins Owner ChangeN/A
Market Cap47.49M
Revenue(TTM)132.55M
Net Income(TTM)6.74M
Analysts80
Price Target15.05 (77.48%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.98% |
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DP19.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.46%
PT rev (3m)8.46%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3%
Revenue NY rev (3m)3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.68 | ||
| Fwd PE | 5.75 | ||
| P/S | 0.36 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.73 | ||
| P/tB | 1.01 | ||
| EV/EBITDA | 4.65 |
EPS(TTM)1.27
EY14.98%
EPS(NY)1.47
Fwd EY17.39%
FCF(TTM)-1.21
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS23.67
BVpS11.54
TBVpS8.36
PEG (NY)0.2
PEG (5Y)0.33
Graham Number18.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.75% | ||
| ROE | 10.43% | ||
| ROCE | 10.81% | ||
| ROIC | 8.04% | ||
| ROICexc | 10.91% | ||
| ROICexgc | 14.1% | ||
| OM | 8.71% | ||
| PM (TTM) | 5.09% | ||
| GM | 26.17% | ||
| FCFM | N/A |
ROA(3y)3.03%
ROA(5y)2.75%
ROE(3y)8.2%
ROE(5y)7.97%
ROIC(3y)6.63%
ROIC(5y)6.34%
ROICexc(3y)10.45%
ROICexc(5y)9.43%
ROICexgc(3y)12.81%
ROICexgc(5y)11.57%
ROCE(3y)8.91%
ROCE(5y)8.53%
ROICexgc growth 3Y10.44%
ROICexgc growth 5Y8.61%
ROICexc growth 3Y11.05%
ROICexc growth 5Y7.72%
OM growth 3Y3.27%
OM growth 5Y3.94%
PM growth 3Y7.81%
PM growth 5Y7.66%
GM growth 3Y-3.21%
GM growth 5Y-2.88%
F-Score5
Asset Turnover0.74
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.36 | ||
| Cap/Depr | 113.41% | ||
| Cap/Sales | 4.68% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.34 | ||
| Altman-Z | 1.81 |
F-Score5
WACC7.07%
ROIC/WACC1.14
Cap/Depr(3y)111.56%
Cap/Depr(5y)102.51%
Cap/Sales(3y)5.01%
Cap/Sales(5y)4.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.41%
EPS 3Y23.97%
EPS 5Y19.97%
EPS Q2Q%34.09%
EPS Next Y33.33%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
EPS Next 5YN/A
Revenue 1Y (TTM)9.07%
Revenue growth 3Y14.06%
Revenue growth 5Y10.34%
Sales Q2Q%21.03%
Revenue Next Year19.23%
Revenue Next 2Y11.86%
Revenue Next 3Y9.07%
Revenue Next 5YN/A
EBIT growth 1Y17.64%
EBIT growth 3Y17.79%
EBIT growth 5Y14.69%
EBIT Next Year89.52%
EBIT Next 3Y28.15%
EBIT Next 5YN/A
FCF growth 1Y-245.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-105.92%
OCF growth 3Y26.58%
OCF growth 5Y-3.68%
SVAS BIOSANA SPA / SVS.MI FAQ
What is the ChartMill fundamental rating of SVAS BIOSANA SPA (SVS.MI) stock?
ChartMill assigns a fundamental rating of 5 / 10 to SVS.MI.
What is the valuation status of SVAS BIOSANA SPA (SVS.MI) stock?
ChartMill assigns a valuation rating of 7 / 10 to SVAS BIOSANA SPA (SVS.MI). This can be considered as Undervalued.
How profitable is SVAS BIOSANA SPA (SVS.MI) stock?
SVAS BIOSANA SPA (SVS.MI) has a profitability rating of 5 / 10.
How financially healthy is SVAS BIOSANA SPA?
The financial health rating of SVAS BIOSANA SPA (SVS.MI) is 3 / 10.
How sustainable is the dividend of SVAS BIOSANA SPA (SVS.MI) stock?
The dividend rating of SVAS BIOSANA SPA (SVS.MI) is 5 / 10 and the dividend payout ratio is 19.64%.